Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avecho Biotechnology Ltd
AVECurrent price
0.003 AUD
+0.0005 AUD (+20.00%)
Last closed
0.0025 AUD
Company
avecho.com.au
ISIN
AU0000047441
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
6 277 297 AUD
Yield for 12 month
-40.00 %
1Y
3Y
5Y
10Y
15Y
AVE
Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia. Address: 2A Westall Road, Clayton, VIC, Australia, 3168
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.53 AUDP/E ratio
–Dividend Yield
–Current Year
+468 972 AUD
Last Year
+1 118 339 AUD
Current Quarter
+309 167 AUD
Last Quarter
+26 850 AUD
Current Year
-220 339 AUD
Last Year
+785 447 AUD
Current Quarter
+131 200 AUD
Last Quarter
-432 062 AUD
Key Figures AVE
1 year
3 years
5 years
10 years
EBITDA
-3 289 723 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-44.33 %
PEG Ratio
–
Return On Equity TTM
-108.69 %
Wall Street Target Price
2.53 AUD
Revenue TTM
336 018 AUD
Book Value
0.00099 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-30.1 %
Dividend Yield
–
Gross Profit TTM
785 447 AUD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics AVE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AVE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
19.05.1997
Forward Annual Dividend Yield
–
Last Split Factor
1.27:1
Payout Ratio
–
Last Split Date
23.04.1999
Dividend Date
–
Stock Valuation AVE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.4563
Price Sales TTM
18.6815
Enterprise Value EBITDA
-6.5575
Price Book MRQ
1.5033
Financials AVE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AVE
For 52 weeks
0.002 AUD
0.005 AUD
50 Day MA
0.0026 AUD
Shares Short Prior Month
–
200 Day MA
0.0033 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart